Please use this identifier to cite or link to this item: http://148.72.244.84:8080/xmlui/handle/xmlui/6600
Title: Prevalence of anti-BK polyomavirus IgG in A Sample of Iraqi renal transplant recipients
Authors: Ghufran Hammoodi Abed
Wisam Mahdi alsaeed
Mustafa Rasul Hussein
Asmaa Baqer Al-Obaidi
Ahmed Sattar Abood
Mohammad A H Al-Dabagh
Keywords: Prevalence
Anti-BK IgG antibodies
Renal transplanted recipients
Issue Date: ديس-2022
Publisher: University of Diyala - College of Medicine
Citation: 10.26505/DJM.23026870816
Series/Report no.: Vol 23;Issue 2
Abstract: Background: BK virus, a human polyomavirus, causes nephropathy and allograft loss in renal transplant recipients. Although it was discovered in 1971, understanding of the humoral immune response to BKV is limited. Objective: To serological detection and level estimation of anti-BK-IgG in renal-transplanted recipients and healthy blood donors as control. Patients and Methods: Serum samples were collected from 106 renal transplant recipient patients and 100 healthy blood donors as control groups, and were analyzed for anti-BK IgG antibodies by using quantitative and qualitative Human BK Virus IgG (BK-IgG) ELISA kit for detection and estimation positivity of BK_IgG and titration. Results: Out of 206 subjects, 114(55.3%) have a positive result for BK-IgG. seropositivity was detected in 54(50.9%) of 106 RTR patients and 60 (60.0%) in the 100 control group, so there was no significant difference between seropositivity of BKV IgG antibody among the studied groups, p =0.191. Conclusion: The highly significant differences between seropositivity of BK-IgG with high levels of serum creatinine.
URI: https://djm.uodiyala.edu.iq/index.php/djm
http://148.72.244.84:8080/xmlui/handle/xmlui/6600
ISSN: Print ISSN 2219-9764
Online ISSN 2617-8982
Appears in Collections:مجلة ديالى الطبية / Diyala Journal of Medicine

Files in This Item:
File Description SizeFormat 
9- 687 Ghufran Hammoodi Abed.pdf441.64 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.